BGEN

Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri - 08/20 - 08:30 AM ET

BIOGEN CONFIRMS FOUR NOMINEES ELECTED TO BOARD - 07/09 - 04:04 PM ET

Carl Icahn says Biogen documents from failed sale process contain 'untruths' - 06/05 - 07:50 AM ET

BIOGEN/ELAN: TYSABRI PATIENTS DISEASE FREE FOR OVER 2 YEARS - 04/15 - 03:21 PM ET

BIOGEN/ELAN: TYSABRI SIGNIFICANTLY INCREASED PATIENTS CONSIDERED DISEASE FREE - 04/15 - 03:20 PM ET

BIOGEN/ELAN: TYSABRI PATIENTS TREATED FOR MULTIPLE SCLEROSIS - 04/15 - 03:20 PM ET

Prix Galien USA Welcomes Eighth Nobel Laureate to its Prestigious Award Committee - 04/14 - 10:10 AM ET

Robert Fildes, Former President of Biogen and Cetus, Joins Vaxart Board - 03/18 - 08:00 AM ET

Biogen, Elan warn of liver injury risks w/Tysabri in letter posted on FDA site - 02/27 - 02:50 PM ET

BIOGEN, ELAN WARN OF LIVER INJURY RISKS W/ TYSABRI IN LETTER POSTED ON FDA SITE - 02/27 - 02:23 PM ET

IMMUNOGEN GETS $1.5M PAYMENT FROM BIOGEN ON BIOGEN SUBMISSION OF BIIB015 - 02/01 - 10:50 AM ET

ICAHN: BIOGEN'S ATTEMPT TO FIND SUITOR 'FLAWED' IN NUMBER OF KEY RESPECTS - 01/28 - 01:44 PM ET

CARL ICAHN CONFIRMS PLAN TO NOMINATE 3 DIRECTORS TO BIOGEN BOARD - 01/28 - 01:43 PM ET

Biogen shares drop on sale failure - 12/13 - 11:23 AM ET

Premarket roundup: Sirius, XM, Biogen - 12/13 - 10:25 AM ET

Mexican bull following in Dolly the sheep's footsteps - 11/16 - 05:16 PM ET

LigoCyte and Biogen to develop anti-CD103 therapies - 09/19 - 04:55 PM ET

Premarket Movers: GM gains, Biogen slips - 09/13 - 10:19 AM ET

Premarket Movers: GM gains, Biogen slips - 09/13 - 10:13 AM ET

<< Back to Stock Index